IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,015,311 | +14.0% | 166,172 | +19.2% | 0.04% | +21.2% |
| Q4 2022 | $890,849 | +106.2% | 139,413 | +208.9% | 0.03% | +120.0% |
| Q3 2022 | $432,000 | -79.3% | 45,137 | -64.0% | 0.02% | -81.0% |
| Q1 2022 | $2,085,000 | -4.6% | 125,229 | +9.3% | 0.08% | -7.1% |
| Q4 2021 | $2,186,000 | -20.7% | 114,534 | +2.4% | 0.08% | -15.8% |
| Q3 2021 | $2,758,000 | +131.2% | 111,834 | +143.8% | 0.10% | +274.1% |
| Q2 2021 | $1,193,000 | -81.1% | 45,868 | -77.0% | 0.03% | -86.2% |
| Q1 2021 | $6,308,000 | +31.1% | 199,247 | +92.2% | 0.20% | +23.3% |
| Q4 2020 | $4,810,000 | +130.6% | 103,669 | +63.6% | 0.16% | -42.4% |
| Q3 2020 | $2,086,000 | – | 63,352 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |